Literature DB >> 14971737

Correlation of bcl-2 and bax with apoptosis in human pituitary adenomas.

Demetrios Sambaziotis1, Nikiforos Kapranos, George Kontogeorgos.   

Abstract

Bcl-2 oncogene and Bax gene play an important role in regulating apoptosis. In the present study, the expression of bcl-2 and bax was investigated and correlated with apoptosis in a series of 81 pituitary adenomas. Bcl-2 and bax proteins were localized by immunohistochemistry and the histoscore (HSC) was assessed by multiplying the immunohistostaining grade (1 to 4) by the staining intensity grade (1 to 3). According to bcl-2/bax HSC the tumors were separated in group A when > or = 1 and group B when < 1. The apoptotic labeling index (ALI) was accessed by the in situ end-labeling (ISEL) technique. Bcl-2 protein was equally detected in functioning and nonfunctioning adenomas with statistically significant higher HSC in nonfunctioning tumors (P < 0.03). Bax protein was immunopositive in the substantial majority of adenomas with significantly higher HSC in functioning as compared to nonfunctioning adenomas (P < 0.0009). The ALI was significantly higher in functioning adenomas as compared to nonfunctioning adenomas (P < 0.04). In addition, ALI was significantly higher in group B than in group A (P < 0.004) and it was correlated with bax HSC (P < 0.004). Finally, the group B of bcl-2/bax significantly predominated in nonfunctioning tumors (P < 0.0009) and in microadenomas (P = 0.05), as compared with functioning adenomas and macroadenomas respectively. In conclusion, our findings suggest that bcl-2 and bax molecules play a role in the regulation of apoptotic mechanisms in pituitary adenomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14971737     DOI: 10.1023/b:pitu.0000011173.04191.37

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  33 in total

1.  A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA.

Authors:  J H Wijsman; R R Jonker; R Keijzer; C J van de Velde; C J Cornelisse; J H van Dierendonck
Journal:  J Histochem Cytochem       Date:  1993-01       Impact factor: 2.479

2.  Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c.

Authors:  X Liu; C N Kim; J Yang; R Jemmerson; X Wang
Journal:  Cell       Date:  1996-07-12       Impact factor: 41.582

3.  Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.

Authors:  N Rampino; H Yamamoto; Y Ionov; Y Li; H Sawai; J C Reed; M Perucho
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

4.  Immunocytochemical accumulation of p53 in corticotroph adenomas: relationship with heat shock proteins and apoptosis.

Authors:  G Kontogeorgos; N Kapranos; E Thodou; D Sambaziotis; S Tsagarakis
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

5.  Expression of bcl-2 oncoprotein in pituitary tumours: comparison with c-myc.

Authors:  D G Wang; C F Johnston; A B Atkinson; A P Heaney; M Mirakhur; K D Buchanan
Journal:  J Clin Pathol       Date:  1996-10       Impact factor: 3.411

6.  Induction of apoptosis in murine ACTH-secreting pituitary adenoma cells by bromocriptine.

Authors:  D Yin; S Kondo; J Takeuchi; T Morimura
Journal:  FEBS Lett       Date:  1994-02-14       Impact factor: 4.124

7.  Apoptosis in the anterior pituitary gland of the rat: studies with estrogen and bromocriptine.

Authors:  N Drewett; J M Jacobi; D A Willgoss; H M Lloyd
Journal:  Neuroendocrinology       Date:  1993-01       Impact factor: 4.914

8.  Tamoxifen inhibits GH3 cell growth in culture via enhancement of apoptosis.

Authors:  S Y Lee; B T Ahn; S H Baik; B L Lee
Journal:  Neurosurgery       Date:  1998-07       Impact factor: 4.654

9.  Bcl-2 Gene Family in Endocrine Pathology: A Review.

Authors:  Kapranos Nikiforos; George Kontogeorgos
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

10.  Bax-deficient mice with lymphoid hyperplasia and male germ cell death.

Authors:  C M Knudson; K S Tung; W G Tourtellotte; G A Brown; S J Korsmeyer
Journal:  Science       Date:  1995-10-06       Impact factor: 47.728

View more
  12 in total

1.  Determination of cell proliferation using Mcm2 antigen and evaluation of apoptosis and TGF-beta1 expression in GH-secreting or clinically nonfunctioning pituitary adenomas.

Authors:  Cristina Micheletto Dallago; Ligia Maria Barbosa-Coutinho; Nelson Pires Ferreira; Rosalva Meurer; Julia Fernanda Semmelmann Pereira-Lima; Miriam da Costa Oliveira
Journal:  Endocr Pathol       Date:  2010-03       Impact factor: 3.943

2.  Evaluation of combined developmental neurological toxicity of di (n-butyl) phthalates and lead using immature mice.

Authors:  Guanghua Mao; Hongyang Liu; Yangyang Ding; Weijie Zhang; Hui Chen; Ting Zhao; Weiwei Feng; Xiangyang Wu; Liuqing Yang
Journal:  Environ Sci Pollut Res Int       Date:  2020-01-08       Impact factor: 4.223

Review 3.  Gene therapy for pituitary tumors.

Authors:  Adriana Seilicovich; Daniel Pisera; Sandra A Sciascia; Marianela Candolfi; Mariana Puntel; Weidong Xiong; Gabriela Jaita; Maria G Castro
Journal:  Curr Gene Ther       Date:  2005-12       Impact factor: 4.391

4.  Cell proliferation parameters and apoptosis indices in pituitary macroadenomas.

Authors:  R M Ruggeri; G Costa; A Simone; A Campennì; A Sindoni; A Ieni; V Cavallari; F Trimarchi; L Curtò
Journal:  J Endocrinol Invest       Date:  2011-09-06       Impact factor: 4.256

Review 5.  Apoptosis: its role in pituitary development and neoplastic pituitary tissue.

Authors:  M F Guzzo; L R S Carvalho; M D Bronstein
Journal:  Pituitary       Date:  2014-04       Impact factor: 4.107

6.  Differential nanoreprotoxicity of silver nanoparticles in male somatic cells and spermatogonial stem cells.

Authors:  Xi-Feng Zhang; Yun-Jung Choi; Jae Woong Han; Eunsu Kim; Jung Hyun Park; Sangiliyandi Gurunathan; Jin-Hoi Kim
Journal:  Int J Nanomedicine       Date:  2015-02-16

7.  Decreased expression of APAF-1 and increased expression of cathepsin B in invasive pituitary adenoma.

Authors:  Cristiana Tanase; Radu Albulescu; Elena Codrici; Bogdan Calenic; Ionela Daniela Popescu; Simona Mihai; Laura Necula; Maria Linda Cruceru; Mihail Eugen Hinescu
Journal:  Onco Targets Ther       Date:  2014-12-22       Impact factor: 4.147

Review 8.  Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System.

Authors:  Federica Barbieri; Stefano Thellung; Roberto Würth; Federico Gatto; Alessandro Corsaro; Valentina Villa; Mario Nizzari; Manuela Albertelli; Diego Ferone; Tullio Florio
Journal:  Int J Endocrinol       Date:  2014-11-17       Impact factor: 3.257

9.  Detection of circulating tumor cells in patients with pituitary tumors.

Authors:  Gao Hua; He Yanjiao; Liu Qian; Wang Jichao; Zhang Yazhuo
Journal:  BMC Cancer       Date:  2018-03-27       Impact factor: 4.430

10.  Cyclooxygenase enzyme and PGE2 expression in patients with functional and non-functional pituitary adenomas.

Authors:  Nasrin Akbari; Mohammad Ghorbani; Vahid Salimi; Alimohammad Alimohammadi; Mohammad E Khamseh; Hamideh Akbari; Mitra Nourbakhsh; Alireza Sheikhi; S Fahimeh Taghavi; Masoumeh Tavakoli-Yaraki
Journal:  BMC Endocr Disord       Date:  2020-03-14       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.